ARTICLE | Company News
China approves Simcere's iguratimod for RA
August 25, 2011 11:37 PM UTC
Simcere Pharmaceutical Group (NYSE:SCR) said China's State Food and Drug Administration approved Iremod iguratimod to treat rheumatoid arthritis. Iremod selectively inhibits cyclooxygenase-2 (COX-2) a...